FDA Inspection 999120 — Matson, Mark A., MD, Clinical Investigator, Prism Research

Matson, Mark A., MD, Clinical Investigator, Prism Research — FEI 3012923755

The FDA completed an inspection of Matson, Mark A., MD, Clinical Investigator, Prism Research on Jan 18, 2017 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Saint Paul, MN (United States)

Additional Details

Clinical Investigator (CI)